Skip to main content
. Author manuscript; available in PMC: 2010 Dec 1.
Published in final edited form as: J Addict Med. 2009 Dec;3(4):211–217. doi: 10.1097/ADM.0b013e3181a0f5dc

Table 1.

Demographics of the study population. In general, the N-acetylcysteine and Modafinil subjects are highly comparable, although Modafinil subjects are statistically significantly younger than N-acetylcysteine subjects. P-values marked with an asterisk are significant at the 0.05 level.

Overall N-acetylcysteine Study Modafinil Study
Total Study Participants 129 66 63
median [IQR] median median Wilcoxon Rank Sum p-value
Age 42 [ 35–47] 44 [35–44] 41 [35–44] 0.037*
Baseline Monthly Cocaine Days 12 [8–19] 12 [8–19] 12 [8–21] 0.888
Days in Study 50 [21–56] 50 [20–55] 51 [23–56] 0.563
% (n) % (n) % (n) χ2 p-value
Gender
 Male 80% (103) 80% (53) 79% (50) 0.894
 Female 20% (26) 20% (13) 21% (13)
Race
 Black 49% (63) 47% (31) 51% (32) 0.664
 White 51% (66) 53% (35) 49% (31)
Baseline Cocaine Use
 Light 35% (45) 29% (19) 41% (26) 0.137
 Heavy 65% (84) 71% (47) 59% (37)
Completion Status
 Completers 56% (72) 53% (35) 59% (37) 0.515
 Non-Completers 44% (57) 47% (31) 41% (37)